ELMD News and Press, Electromed Inc. From 02/23/24

2024-02-23 23:07:00 ET Summary Electromed reported an impressive quarter and expects beneficial results for 2024, with a total market opportunity of 4.2 million Bronchiectasis patients. The company's growth strategies, including direct-to-consumer marketing and internationalizatio...

2024-02-13 22:18:05 ET Electromed, Inc. (ELMD) Q2 2024 Earnings Conference Call February 13, 2024 17:00 ET Company Participants Mike Cavanaugh - Investor Relations, ICR Westwicke Jim Cunniff - President & Chief Executive Officer Brad Nagel - Chief Financial O...

2024-02-13 16:15:17 ET More on Electromed Seeking Alpha’s Quant Rating on Electromed Historical earnings data for Electromed Financial information for Electromed Read the full article on Seeking Alpha For further details see: Electromed GAA...

Growth initiatives drive record revenue, improve margins and enhance operational efficiency Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the...

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 second quarter ended December 31, 2023, on February ...

Electromed, Inc. (NYSE American: ELMD) today announced it has entered into a distribution agreement with Marathon Medical Corp., a medical supply distribution company and service-disabled veteran-owned small business (SDVOSB). SmartVest ® Airway Clearance System, which is designed for Hi...

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the v...

2024-01-18 09:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-18 16:56:20 ET Electromed ( NYSE: ELMD ) disclose that director Andrew Summers bought ~28.8K common shares at $10.5/share for ~$302.4K SEC Filing For further details see: Electromed director Andrew Summers purchases shares worth ~$302.4K

2023-12-04 20:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...